Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.

Journal: Journal of the American College of Cardiology
Published Date:

Abstract

BACKGROUND: Better risk stratification strategies are needed to enhance clinical care and trial design in heart failure with preserved ejection fraction (HFpEF).

Authors

  • Julio A Chirinos
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: julio.chirinos@uphs.upenn.edu.
  • Alena Orlenko
    Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA.
  • Lei Zhao
    Brain Cognition and Brain-Computer Intelligence Integration Group, Kunming University of Science and Technology, Kunming, China.
  • Michael D Basso
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Mary Ellen Cvijic
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Zhuyin Li
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Thomas E Spires
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Melissa Yarde
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Zhaoqing Wang
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Dietmar A Seiffert
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Stuart Prenner
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Payman Zamani
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Priyanka Bhattacharya
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Anupam Kumar
    Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kenneth B Margulies
    Cardiovascular Research Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
  • Bruce D Car
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • David A Gordon
    Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Jason H Moore
    University of Pennsylvania, Philadelphia, PA, USA.
  • Thomas P Cappola
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.